Burning Rock Biotech Ltd (BNR)

Burning Rock Reports First Quarter 2026 Financial Results

GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Burning Rock Publishes 2025 Annual Report on Form 20-F

GUANGZHOU, China, April 28, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Burning Rock Announces Founder’s Purchase of Its ADSs

GUANGZHOU, China, April 02, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

GUANGZHOU, China, March 12, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Burning Rock Announces Founder’s Purchase of Its ADSs

GUANGZHOU, China, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]